Fed. Circ. Revives Dispute Over Spinal Nerve Injury Drug
A Federal Circuit panel on Monday revived a dispute over who first invented drug treatments for spinal nerve injuries, ruling that a patent application was not too broad by describing both...To view the full article, register now.
Already a subscriber? Click here to view full article